RFK Jr.'s vaccine committee, which includes some skeptics, is considering recommending restrictions on the hepatitis B vaccine for newborns, potentially delaying its administration. This is concerning because the vaccine has been crucial in reducing newborn hepatitis B infections by 68% in the first decade of routine immunization. The proposed changes could undermine public health efforts and lead to increased risks for infants.

RFK Jr.'s vaccine advisory panel is likely to recommend delaying the hepatitis B shot for newborns, raising concerns among doctors about a potential resurgence of the disease in U.S. children.